5 Stocks US Senators Are Selling

2. Amyris, Inc. (NASDAQ:AMRS)

Number of Hedge Fund Holders: 15

Amyris, Inc. (NASDAQ:AMRS) is a California-based synthetic biotechnology company that caters to the clean health and beauty, flavors, and fragrance markets in Europe, North America, Asia, and South America. The company’s 2022 outlook is extremely bullish, and its newly issued financial guidance calls for a 150% increase in consumer revenue year-over-year.

Dianne Feinstein is a senior member of the United States senate from California. On January 10, she sold shares of Amyris, Inc. (NASDAQ:AMRS) valued at between $50,000 and $100,000. The transaction was reported 36 days later on February 19. 

On March 2, Cowen analyst Steven Mah initiated coverage of Amyris, Inc. (NASDAQ:AMRS) with an unchanged Outperform rating. He expects the high-single digit trillion dollar synthetic biology market to grow to mid-double digit trillions by 2025.

According to Insider Monkey’s fourth quarter database, 15 hedge funds were bullish on Amyris, Inc. (NASDAQ:AMRS), with combined stakes of $169.2 million, compared to 17 funds in the earlier quarter, holding stakes in Amyris, Inc. (NASDAQ:AMRS) worth $403.4 million. Albert Cha and Frank Kung’s Vivo Capital is the biggest stakeholder of the company, with 11.6 million shares valued at approximately $63 million.